Formation Bio

Formation Bio

Private
New York City, New YorkHealthcare & Life Scienceshttps://www.formation.bio

Last Round

Series D

6/1/2024

Total Funding Raised

$615M

Company Overview

Trialspark is a biotechnology company that offers a platform to streamline drug development by establishing clinical trial sites within existing practices and utilizing a network of certified research coordinators supported by advanced software and technology.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Clinical Trials, Medical AI

Business Model

B2B

Customer Profile

Revenue Share

AI Layer

Infrastructure

Keywords

AI drug developmentdrug development platformclinical trial accelerationTechBioRoivant modelAI for clinical trialsdrug asset acquisitionclinical trial automationasset-centric biotechdrug in-licensingtech-enabled pharmaclinical-stage assetsexternal innovationclinical trial engine

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Formation Bio Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Formation Bio Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series D6/1/2024
Series C9/30/2021
Series B10/15/2018

Key People

Founding team and executive leadership

Linhao Zhang

Co-founder CTO

Founding Team

Benjamine Liu

CEO And Co-founder At Formation Bio

Founding Team

Dan Neil

Chief Technology Officer

Executive Team

James Leslie

Chief Financial Officer

Executive Team

Formation Bio Investors

Notable investors and investment history

InvestorRounds
Andreessen HorowitzSeries D
S32Series C
SV Angel Growth FundSeries D
Thrive CapitalSeries C, Series D, Series B
Dragoneer Investment GroupSeries C
ArrowMark PartnersSeries C
Sequoia CapitalSeries C, Series B, Series D, Series A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 2, 2025

    Former Pfizer CSO Mikael Dolsten joins as advisor.

  • Jun 1, 2024

    $372M round led by Andreessen Horowitz.

Formation Bio Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Formation Bio Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Formation Bio's valuation, stock price, and market status.

Firmographic Details

HeadquartersNew York City, New York
Employee Range193
Year Founded2016
Last Funding6/1/2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







DisclaimerAll investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.